Bill Text: VA HB1460 | 2020 | Regular Session | Prefiled
Bill Title: Cannabidiol oil and THC-A oil; certification for use of oil.
Spectrum: Partisan Bill (Republican 1-0)
Status: (Passed) 2020-04-06 - Governor: Acts of Assembly Chapter text (CHAP0730) [HB1460 Detail]
Download: Virginia-2020-HB1460-Prefiled.html
Be it enacted by the General Assembly of Virginia:
1. That §54.1-3442.7 of the Code of Virginia is amended and reenacted as follows:
§54.1-3442.7. Dispensing cannabidiol oil and THC-A oil; report.
A. A pharmaceutical processor shall dispense or deliver
cannabidiol oil or THC-A oil only in person to (i) a patient who is a Virginia resident, has
been issued a valid written certification,
and is registered with the Board pursuant to §54.1-3408.3, (ii) such patient's
registered agent, or (iii) if such patient is a minor or an incapacitated adult
as defined in §18.2-369, such patient's parent or legal guardian who is a Virginia resident
and is registered with the Board pursuant to §54.1-3408.3.
Prior to the initial dispensing of each written certification, the pharmacist
or pharmacy technician at the location of the pharmaceutical processor shall
make and maintain for two years a paper or electronic copy of the written
certification that provides an exact image of the document that is clearly
legible; shall view a current photo identification of the patient, registered
agent, parent, or legal guardian; and shall verify current board registration
of the practitioner and the corresponding patient, registered agent, parent, or
legal guardian. Prior to any subsequent dispensing of each written
certification, the pharmacist, pharmacy technician, or delivery agent shall
view the current written certification; a current photo identification of the
patient, registered agent, parent, or legal guardian; and the current board
registration issued to the patient, registered agent, parent, or legal
guardian. No pharmaceutical processor shall dispense more than a 90-day supply
for any patient during any 90-day period. The Board shall establish in
regulation an amount of cannabidiol oil or THC-A oil that constitutes a 90-day supply
to treat or alleviate the symptoms of a patient's diagnosed condition or
disease.
B. A pharmaceutical processor shall dispense only cannabidiol oil and THC-A oil that has been cultivated and produced on the premises of a pharmaceutical processor permitted by the Board. A pharmaceutical processor may begin cultivation upon being issued a permit by the Board.
C. The Board shall report annually by December 1 to the Chairmen of the House and Senate Committees for Courts of Justice on the operation of pharmaceutical processors issued a permit by the Board, including the number of practitioners, patients, registered agents, and parents or legal guardians of patients who have registered with the Board and the number of written certifications issued pursuant to §54.1-3408.3.
D. The concentration of tetrahydrocannabinol in any THC-A oil on site may be up to 10 percent greater than or less than the level of tetrahydrocannabinol measured for labeling. A pharmaceutical processor shall ensure that such concentration in any THC-A onsite is within such range and shall establish a stability testing schedule of THC-A oil.